Method for detecting nadroparin calcium product
Patent Information
- Authority / Receiving Office
- CN · China
- Patent Type
- Applications(China)
- Current Assignee / Owner
- 广东三生制药有限公司
- Publication Date
- 2013-11-20
Smart Images
Figure 1 Figure 2 Figure 3
Abstract
Description
technical field
[0001] The invention relates to the technical field of ultraviolet-visible spectrophotometry detection, in particular to a method for rapidly detecting nadroparin calcium products. Background technique
[0002] Heparin drugs are highly sulfated mucopolysaccharide sulfates, which are widely used in the treatment of cardiovascular and cerebrovascular diseases and hemodialysis. Among them, in the treatment of severe hemodialysis, they are currently the only specific drugs available. At present, low molecular weight heparin (Low Molecular Weight Heparin, LMWH) is dominant in the heparin drug market, that is, heparin derivatives with an average molecular weight distribution of 3500-6500Da. Because compared with unfractionated heparin (UFH), LMWH has many obvious advantages in clinical application, including clearer pharmacological effects, greatly reduced side effects, longer duration of antithrombotic activity, and higher bioavailability. There are five common L...